ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 5th, 2016 • DanDrit Biotech USA, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledApril 5th, 2016 Company Industry JurisdictionASSET PURCHASE AGREEMENT (the “Agreement”) is made as of this 4th day of April, 2016 (the “Signing Date”) by and among OncoSynergy Inc., a Delaware corporation (“OS”) and DanDrit BioTech USA Inc., a Delaware corporation (“DanDrit”). Each of the parties to this Agreement is individually referred to herein as a “Party” and collectively as the “Parties”.